NYMOX PHARM CORP (NYMXF) Total Assets by Year
NYMOX PHARM CORP closed fiscal year 2024 with $654K in total assets, $7.4M in total liabilities and -$6.8M in shareholder equity. Total assets rose 4.3% from the prior fiscal year. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters NYMOX PHARM CORP has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NYMXF Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F | FY1820-F | FY1720-F | FY1620-F | FY1520-F |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $654K+4.3% | $627K-61.4% | $1.6M+12.6% | $1.4M-66.8% | $4.3M-20.9% | $5.5M-32.0% | $8.1M+724.9% | $979K-52.4% | $2.1M+188.9% | $712K |
| Total Liabilities | $7.4M+95.5% | $3.8M+80.4% | $2.1M+8.1% | $1.9M-11.3% | $2.2M+7.7% | $2.0M+90.0% | $1.1M-51.8% | $2.2M-3.0% | $2.3M-24.9% | $3.1M |
| Total Equity | -$6.8Mn/m | -$3.2Mn/m | -$482Kn/m | -$506K-123.6% | $2.1M-37.8% | $3.4M-50.8% | $7.0Mn/m | -$1.3Mn/m | -$241Kn/m | -$2.4M |
NYMXF Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2420-F | Q3'246-K | Q4'2320-F | Q3'236-K | Q2'236-K | Q1'236-K | Q4'2220-F | Q3'226-K | Q2'226-K | Q1'226-K | Q4'2120-F | Q3'216-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $654K+4.3% | $624K-6.7% | $627K-61.4% | $669K-78.7% | $271K-93.9% | $575K-53.6% | $1.6M+12.6% | $3.1M-18.4% | $4.5M-32.9% | $1.2M-14.9% | $1.4M-66.8% | $3.9M-32.9% |
| Total Liabilities | $7.4M+95.5% | $6.9M+169.2% | $3.8M+80.4% | $2.6M+8.6% | $3.1M+40.4% | $2.4M-9.7% | $2.1M+8.1% | $2.4M+4.4% | $2.2M+14.2% | $2.6M+79.1% | $1.9M-11.3% | $2.3Mn/m |
| Total Equity | -$6.8Mn/m | -$6.3Mn/m | -$3.2Mn/m | -$1.9M-346.1% | -$2.9M-228.9% | -$1.8Mn/m | -$482Kn/m | $773K-51.2% | $2.2M-52.6% | -$1.4Mn/m | -$506K-123.6% | $1.6M-95.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More NYMOX PHARM CORP financials
Frequently Asked Questions
What was NYMOX PHARM CORP's total assets in fiscal year 2024?
NYMOX PHARM CORP closed fiscal year 2024 with $654K in total assets, $7.4M in total liabilities and -$6.8M in shareholder equity.
How fast is NYMOX PHARM CORP's total assets growing?
NYMOX PHARM CORP (NYMXF) total assets rose by 4.3% year over year, from $627K to $654K in fiscal year 2024.
How has NYMOX PHARM CORP's total assets changed over the years?
Across the 10 fiscal years this page covers, NYMOX PHARM CORP (NYMXF) total assets went from $712K in fiscal year 2015 to $654K in fiscal year 2024.
What was NYMOX PHARM CORP's total assets in the most recent quarter?
NYMOX PHARM CORP (NYMXF) reported $654K in total assets in Q4 2024. This represents an increase of 4.3% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what NYMOX PHARM CORP (NYMXF) reported on that line in every period on record.